1Krishnaveni, M & Mirunalini, S (2010) Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J Basic Clin Physiol Pharmacol 21, 93–105.
2Chen, TS, Liou, SY & Chang, YL (2009) Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med 37, 19–25.
3Rege, NN, Thatte, UM & Dahanukar, SA (1999) Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 13, 275–291.
4Kumar, NP, Annamalai, AR & Thakur, RS (2009) Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats. Indian J Exp Biol 47, 737–742.
5Nicolis, E, Lampronti, I, Dechecchi, MC, et al. (2008) Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol 8, 1672–1680.
6Sai Ram, M, Neetu, D, Deepti, P, et al. (2003) Cytoprotective activity of amla (Emblica officinalis) against chromium (VI) induced oxidative injury in murine macrophages. Phytother Res 17, 430–433.
7Steffens, S & Mach, F (2004) Inflammation and atherosclerosis. Herz 29, 741–748.
8Levi, M & van der Poll, T (2010) Inflammation and coagulation. Crit Care Med 38, S26–S34.
9Sprague, AH & Khalil, RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78, 539–552.
10Vanhoutte, PM, Shimokawa, H, Tang, EH, et al. (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196, 193–222.
11Nemerson, Y (1988) Tissue factor and hemostasis. Blood 71, 1–8.
12Wada, H, Wakita, Y & Shiku, H (1995) Tissue factor expression in endothelial cells in health and disease. Blood Coagul Fibrinolysis 6, S26–S31.
13Ruggeri, ZM (2001) Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 14, 257–279.
14Palmer, DS, Aye, MT, Ganz, PR, et al. (1994) Adenosine nucleotides and serotonin stimulate von Willebrand factor release from cultured human endothelial cells. Thromb Haemost 72, 132–139.
15Bochner, BS, Luscinskas, FW, Gimbrone, MA, et al. (1991) Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 173, 1553–1557.
16Springer, TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301–314.
17Mantovani, A, Bussolino, F & Introna, M (1997) Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol Today 18, 231–240.
18Deguchi, H, Takeya, H, Wada, H, et al. (1997) Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes. Blood 90, 2345–2356.
19Kishiwada, M, Hayashi, T, Yuasa, H, et al. (2008) Regulatory mechanisms of C4b-binding protein (C4BP) alpha and beta expression in rat hepatocytes by lipopolysaccharide and interleukin-6. J Thromb Haemost 11, 1858–1867.
20Patel, SS & Goyal, RK (2012) Emblica officinalis Geart: a comprehensive review on phytochemistry, pharmacology and ethnomedicinal uses. Res J Med Plant 6, 6–16.
21Barthakur, NN & Arnold, NP (1991) Chemical analysis of the emblic (Phyllanthus emblica L.) and its potential as a food source. Sci Hortic 47, 99–105.
22Ghosal, S, Tripati, VK & Chauhan, S (1996) Active constituents of Emblica officinalis: part 1 – the chemistry and antioxidant effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem 3, 941–948.
23Zhang, YJ, Tanaka, T, Yang, CR, et al. (2001) New phenolic constituents from the fruit juice of Phyllanthas emblica. Chem Pharm Bull (Tokyo) 49, 537–540.
24Zhang, YJ, Abe, T, Tanaka, T, et al. (2001) Phyllanemblinins A–F, new ellagitannins from Phyllanthus emblica. J Nat Prod 64, 1527–1532.
25Jaffe, EA (1987) Cell biology of endothelial cells. Hum Pathol 18, 234–239.
26Grandel, U & Grimminger, F (2003) Endothelial responses to bacterial toxins in sepsis. Crit Rev Immunol 23, 267–299.
27Volk, T & Kox, WJ (2000) Endothelium function in sepsis. Inflamm Res 49, 185–198.
28Calandra, T (2001) Pathogenesis of septic shock: implications for prevention and treatment. J Chemother 1, 173–180.
29Dauphinee, SM & Karsan, A (2006) Lipopolysaccharide signaling in endothelial cells. Lab Invest 86, 9–22.
30Erlich, J, Fearns, C, Mathison, J, et al. (1999) Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 67, 2540–2546.
31Levi, M (2010) The coagulant response in sepsis and inflammation. Hamostaseologie 30, 10–12.
32Asmawi, MZ, Kankaanranta, H, Moilanen, E, et al. (1993) Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacother 45, 581–584.
33Ihantola-Vormisto, A, Summanen, J, Kankaanranta, H, et al. (1997) Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 63, 518–524.
34Jaijoy, K, Soonthornchareonnon, N, Panthong, A, et al. (2010) Anti-inflammatory and analgesic activities of the water extract from the fruit of Phyllanthus emblica Linn. Int J App Res Nat Prod 3, 28–35.
35Rao, TP, Sakaguchi, N, Juneja, LR, et al. (2005) Amla (Embica officianalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats. J Med Food 8, 362–368.
36Yokozawa, T, Kim, HY, Kim, HJ, et al. (2007) Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr 97, 1187–1195.
37Baliga, MS & Dsouza, JJ (2011) Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer. Eur J Cancer Prev 20, 225–239.
38Reddy, VD, Padmavathi, P, Gopi, S, et al. (2010) Protective effect of Emblica officinalis against alcohol-induced hepatic injury by ameliorating oxidative stress in rats. Indian J Clin Biochem 25, 419–424.
39Akhtar, MS, Ramzan, A, Ali, A, et al. (2011) Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr 62, 609–616.
40Saeed, S & Tariq, P (2007) Antibacterial activities of Emblica officinalis and Corandrum stivum against gram negative urinary pathogens. Pak J Pharm Sci 20, 32–35.